Literature DB >> 23780629

[Digitalis and theophylline: old and superfluous?].

M Gosch1, P Dovjak.   

Abstract

Digitalis and theophylline are some of the oldest drugs used to treat cardiopulmonary diseases. Despite a long history, the evidence for both drugs is still inconsistent, in parts negative. In this context, geriatric medicine represents a special area of conflict. On the one hand, both drugs may play a role in the treatment of advanced heart failure and chronic obstructive pulmonary disease, particularly in the treatment of symptoms. On the other hand, both drugs are often listed as potentially inappropriate medications for the elderly. This paper discusses the evidence for both drugs based on the current literature.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23780629     DOI: 10.1007/s00391-013-0497-5

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  35 in total

1.  Expression and activity of histone deacetylases in human asthmatic airways.

Authors:  Kazuhiro Ito; Gaetano Caramori; Sam Lim; Tim Oates; K Fan Chung; Peter J Barnes; Ian M Adcock
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

2.  [Drug therapy in the elderly: too much or too little, what to do? A new assessment system: fit for the aged (FORTA].

Authors:  M Wehling
Journal:  Dtsch Med Wochenschr       Date:  2008-10-22       Impact factor: 0.628

3.  Mechanism of theophylline-induced inotropic effects on foreshortened canine diaphragm.

Authors:  G Gayan-Ramirez; S Janssens; B Himpens; M Decramer
Journal:  Eur Respir J       Date:  1995-11       Impact factor: 16.671

4.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

5.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

6.  Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Authors:  Ali Ahmed; Michael W Rich; Jerome L Fleg; Michael R Zile; James B Young; Dalane W Kitzman; Thomas E Love; Wilbert S Aronow; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

7.  Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.

Authors:  Mihai Gheorghiade; Kanan Patel; Gerasimos Filippatos; Stefan D Anker; Dirk J van Veldhuisen; John G F Cleland; Marco Metra; Inmaculada B Aban; Stephen J Greene; Kirkwood F Adams; John J V McMurray; Ali Ahmed
Journal:  Eur J Heart Fail       Date:  2013-01-25       Impact factor: 15.534

8.  STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

Authors:  P Gallagher; C Ryan; S Byrne; J Kennedy; D O'Mahony
Journal:  Int J Clin Pharmacol Ther       Date:  2008-02       Impact factor: 1.366

Review 9.  [Bronchial asthma and chronic obstructive pulmonary disease with acute exacerbation: preclinical differential diagnostic and emergency treatment].

Authors:  B Friege; L Friege; J Pelz; M Weber; T von Spiegel; S Schröder
Journal:  Anaesthesist       Date:  2009-06       Impact factor: 1.041

10.  [From Digitalis purpurea to toad skin. An historical view of digitalis-like mammalian hormones ].

Authors:  E Ritz; W Schoner
Journal:  Dtsch Med Wochenschr       Date:  2008-12-09       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.